Leica agrees to acquire Bioptigen

Leica Microsystems intends to acquire Bioptigen Inc. “to strengthen its position in the ophthalmology market,” the company announced in a press release after a definitive agreement between the two was signed.Leica develops and manufactures microscopes and scientific instruments; Bioptigen develops and manufactures OCT technology.